{
    "N/R/U": null,
    "Applicant": "GlaxoSmithKline Biologicals",
    "BLA Number": "125265",
    "Proprietary Name": "Rotarix",
    "Proper Name": "Rotavirus Vaccine, Live, Oral",
    "BLA Type": "351(a)",
    "Strength": "106.0CCID50",
    "Dosage Form": "Suspension",
    "Route of Administration": "Oral",
    "Product Presentation": "Oral Applicator",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "4-Nov-22",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": " ",
    "Supplement Number": "645",
    "Submission Type": "Supplement",
    "License Number": "1617",
    "Product Number": "3",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}